Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Biohaven Returns To Well With Bristol License, Acquires Channel Biosciences
Feb 25 2022
•
By
Joseph Haas
Biohaven's new deals add two up-and-coming assets to its pipeline • Source: Alamy
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Strategy
More from Business